International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M., ...Daha Fazla

RHEUMATOLOGY, cilt.56, sa.12, ss.2102-2108, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56 Sayı: 12
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1093/rheumatology/kex305
  • Dergi Adı: RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2102-2108
  • Anahtar Kelimeler: interleukin-1 inhibitors, anakinra, canakinumab, pregnancy, autoinflammatory disease, CAPS, TRAPS, biologic therapies, familial Mediterranean fever, adult onset stills disease, FAMILIAL MEDITERRANEAN FEVER, AUTOINFLAMMATORY DISEASES, REPRODUCTIVE-SYSTEM, ANAKINRA, EMBRYO
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective. To provide outcome data concerning pregnancies exposed to the Interleukin-1 (IL-1) inhibitors prior to conception in both men and women, during pregnancy and breast feeding.